White label ELPA - ClinicalTrials.eu

Long-term Safety Study of Cholic Acid for Patients with Bile Acid Synthesis Defects

Not recruiting

3 1 1 1
Investigated Diseases:
- Bile acid synthesis disorder
Investigated Drugs:
- Cholic Acid
Study on the Safety and Effects of BIIB122 for Patients with LRRK2-Associated Parkinson’s Disease

Not recruiting

2 1
Investigated Diseases:
- Parkinson’s disease
Investigated Drugs:
- N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
Study of Sotatercept for People with Pulmonary Arterial Hypertension

Not recruiting

2 1 1 1
Investigated Diseases:
- Pulmonary arterial hypertension
Investigated Drugs:
- Sotatercept
+2
Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Not recruiting

3 1
Investigated Diseases:
- Multiple sclerosis
Investigated Drugs:
- Frexalimab
+7
Study on the Effects of 3 vs 6 Cycles of Platinum-based Chemotherapy and Avelumab in Patients with Advanced Urothelial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
- Avelumab
Study Comparing Dabigatran with Ticagrelor or Clopidogrel for Patients with Acute Coronary Syndrome Undergoing PCI

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute coronary syndrome
Investigated Drugs:
- Ticagrelor
Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Not recruiting

3 1 1
Investigated Diseases:
- Cardiac amyloidosis
Investigated Drugs:
- Patisiran
+2
Study on FX06 for Improving Acute Respiratory Distress Syndrome in Patients

Not recruiting

2 1
Investigated Diseases:
- Acute respiratory distress syndrome
Investigated Drugs:
- Glutenin
Study of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections

Not recruiting

2 1 1 1
Investigated Diseases:
- Skin bacterial infection
Investigated Drugs:
- Oritavancin
- Aztreonam
+2
Study of Isatuximab, Pomalidomide and Dexamethasone combination for multiple myeloma patients who previously received Lenalidomide and Proteasome Inhibitor therapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies